After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Caredx Inc is listed on the NASDAQ in the Healthcare sector while operating in the Diagnostics & Research industry. The current market capitalization of Caredx Inc is $417.86M. A total of 0.67 million shares were traded on the day, compared to an average of 913.45K shares.
In the most recent transaction, Seeto Reginald sold 2,818 shares of CDNA for 6.91 per share on Oct 02 ’23. After the transaction, the insider now owns 479,164 company shares. In a previous transaction on Sep 05 ’23, Seeto Reginald sold 2,819 shares at 9.49 per share. CDNA shares that the insider owns now total 481,982.
Among the insiders who sold shares, Seeto Reginald disposed of 576 shares on Aug 14 ’23 at a per-share price of $8.89. This resulted in the insider holding 484,801 shares of CDNA after the transaction. In another insider transaction, Seeto Reginald sold 2,819 shares at $11.35 per share on Aug 02 ’23. Company shares held by the insider now total 486,051.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, CDNA has a high of $12.93 and a low of $4.80.
As of this writing, CDNA has an earnings estimate of $Carvana Co. per share for the current quarter. EPS was calculated based on a consensus of Strategic CRISPR & Gene Editing estimates, with a high estimate of $Cadence Design Systems, Inc. per share and a lower estimate of $Ginkgo Bioworks Holdings, Inc..
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. CDNA’s latest balance sheet shows that the firm has $348.49M in Cash & Short Term Investments as of fiscal 2021. There were $21.35M in debt and $77.30M in liabilities at the time. Its Book Value Per Share was $5.07, while its Total Shareholder’s Equity was $465.88M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CDNA is Buy with a score of 4.00.
